Natural Course and Therapeutic Effect of Chronic Pancreatitis
Launched by CHANGHAI HOSPITAL · Apr 6, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying chronic pancreatitis, a long-term condition that affects the pancreas, which is an organ that helps with digestion and blood sugar control. The main goal of the study is to gather information from patients with chronic pancreatitis to improve how doctors diagnose and treat this condition. Researchers will collect various types of information, including health history, medical images, biological samples, and follow-up data to better understand the disease and its effects.
If you or a family member have been diagnosed with chronic pancreatitis, you may be eligible to participate in this study. The only requirement is that participants must agree to take part by signing an informed consent form. Those who join can expect to provide information about their health and may undergo some tests, but the study is focused on gathering data rather than providing treatment. This research aims to help improve care for future patients with chronic pancreatitis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with chronic pancreatitis.
- Exclusion Criteria:
- • Patients who refuse to sign informed consent.
About Changhai Hospital
Changhai Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence, the hospital integrates cutting-edge medical technologies and a multidisciplinary approach to patient care. Changhai Hospital actively collaborates with research organizations and healthcare professionals to conduct rigorous clinical trials aimed at developing new treatments and improving patient outcomes. By prioritizing patient safety and ethical standards, the hospital plays a pivotal role in contributing to the advancement of medical knowledge and the enhancement of therapeutic options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Zhaoshen Li, M.D.
Study Chair
Changhai Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported